HeartBeam, Inc. (BEAT) 10-Year Financial Performance & Capital Metrics

BEAT • • Industrial / General

HealthcareHealthcare ITTelehealth & Virtual Care PlatformsSpecialized Telehealth Solutions

AboutHeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiogram machine and a cloud-based diagnostic software system to address the rapidly growing field of remote patient monitoring. The company was incorporated in 2015 and is headquartered in Santa Clara, California.Show more

Revenue $0
EBITDA -$20M
Net Income -$19M -32.9%
EPS (Diluted) -0.73 -1.4%
Gross Margin -
EBITDA Margin -
Operating Margin -
Net Margin -
ROE -221.11% -38.3%
ROIC -
Debt/Equity -
Interest Coverage -

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Momentum leader: RS Rating 91 (top 9%)

✗Weaknesses

✗Weak Piotroski F-Score: 1/9
✗Shares diluted 31.0% in last year
✗Trading more than 30% below 52-week high
✗Expensive at 35.4x book value
✗Low asset turnover indicates capital-intensive operations

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y-

3Y-

TTM-

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM-11.94%

EPS CAGR

10Y-

5Y-

3Y-

TTM5.71%

ROCE

10Y Avg-59.07%

5Y Avg-152.87%

3Y Avg-186.16%

Latest-226.1%

Peer Comparison

Specialized Telehealth Solutions

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
VSEEWVSee Health, Inc.	1.52M	0.09	-0.02	78.42%	-85.76%
VSEEVSee Health, Inc.	14.7M	0.44	-0.08	80.74%	-85.76%
MGRXMangoceuticals, Inc.	10.82M	0.66	-0.15	-15.81%	-42.45%	-126.03%		0.02
BEATHeartBeam, Inc.	75.78M	2.20	-3.01			-50.79%
OMDAOmada Health	906.26M	15.65	-18.41	38.29%	-16.82%	-16.98%		0.47
HNGEHinge Health, Inc.	1.66B	43.76	-291.73	33.37%	-3.06%	-2.83%	2.73%	0.03

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	178.51M	208.33M	286.78M	399.47M	0	0	0	0	0	0
Revenue Growth %	0.07%	0.17%	0.38%	0.39%	-1%	-	-	-	-	-
Cost of Goods Sold+	71.96M	78.88M	114.41M	148.99M	0	0	0	0	0	0
COGS % of Revenue	0.4%	0.38%	0.4%	0.37%	-	-	-	-	-	-
Gross Profit+	106.56M	129.45M	172.37M	250.49M	0	0	0	0	0	0
Gross Margin %	0.6%	0.62%	0.6%	0.63%	-	-	-	-	-	-
Gross Profit Growth %	0.14%	0.21%	0.33%	0.45%	-1%	-	-	-	-	-
Operating Expenses+	82.98M	93.59M	135.02M	166.48M	294K	788K	2.29M	13.03M	15.31M	19.89M
OpEx % of Revenue	0.46%	0.45%	0.47%	0.42%	-	-	-	-	-	-
Selling, General & Admin	75.87M	85.23M	123.92M	155.28M	253K	655K	2.03M	7.35M	8.52M	8.84M
SG&A % of Revenue	0.42%	0.41%	0.43%	0.39%	-	-	-	-	-	-
Research & Development	7.11M	8.36M	11.1M	11.21M	41K	133K	255K	5.68M	6.8M	11.05M
R&D % of Revenue	0.04%	0.04%	0.04%	0.03%	-	-	-	-	-	-
Other Operating Expenses	0	0	0	0	0	0	0	0	0	0
Operating Income+	23.58M	35.86M	37.35M	84M	-294K	-788K	-2.29M	-13.03M	-15.31M	-19.89M
Operating Margin %	0.13%	0.17%	0.13%	0.21%	-	-	-	-	-	-
Operating Income Growth %	1.06%	0.52%	0.04%	1.25%	-1%	-1.68%	-1.9%	-4.7%	-0.18%	-0.3%
EBITDA+	36.07M	50.13M	65.91M	124.17M	0	0	-2.29M	0	0	-19.88M
EBITDA Margin %	0.2%	0.24%	0.23%	0.31%	-	-	-	-	-	-
EBITDA Growth %	0.5%	0.39%	0.31%	0.88%	-1%	-	-	1%	-	-
D&A (Non-Cash Add-back)	12.49M	14.27M	28.56M	40.17M	294K	788K	0	13.03M	15.31M	7K
EBIT	0	0	-5.5M	50.93M	-294K	-788K	-2.29M	-12.96M	-14.64M	-19.89M
Net Interest Income+	0	0	0	0	-242K	-280K	-2.16M	0	675K	446K
Interest Income	0	0	0	0	0	0	2.17K	66K	675K	446K
Interest Expense	0	0	4.9M	9.43M	242K	280K	2.17M	66K	0	0
Other Income/Expense	-15.68M	-20.09M	-47.75M	-42.5M	-242K	-280K	-2.14M	69K	675K	439K
Pretax Income+	7.9M	15.77M	-10.4M	41.5M	-536K	-1.07M	-4.43M	-12.96M	-14.64M	-19.45M
Pretax Margin %	0.04%	0.08%	-0.04%	0.1%	-	-	-	-	-	-
Income Tax+	468K	-37.67M	6.75M	-370K	0	0	0	0	0	0
Effective Tax Rate %	0.94%	3.39%	1.53%	1.03%	1%	1%	1%	1%	1%	1%
Net Income+	7.43M	53.44M	-15.96M	42.82M	-536K	-1.07M	-4.43M	-12.96M	-14.64M	-19.45M
Net Margin %	0.04%	0.26%	-0.06%	0.11%	-	-	-	-	-	-
Net Income Growth %	1.76%	6.19%	-1.3%	3.68%	-1.01%	-0.99%	-3.15%	-1.93%	-0.13%	-0.33%
Net Income (Continuing)	7.43M	53.44M	-15.96M	42.82M	-536K	-1.07M	-4.43M	-12.96M	-14.64M	-19.45M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)+	0.26	1.75	-0.53	1.20	-0.10	-0.14	-0.56	-1.59	-0.72	-0.73
EPS Growth %	1.7%	5.73%	-1.3%	3.26%	-1.08%	-0.47%	-3%	-1.84%	0.55%	-0.01%
EPS (Basic)	0.27	1.91	-0.53	1.20	-0.10	-0.14	-0.56	-1.59	-0.72	-0.73
Diluted Shares Outstanding	29.09M	30.49M	30.39M	35.78M	8.17M	8.17M	7.81M	8.17M	20.33M	26.65M
Basic Shares Outstanding	27.12M	27.92M	30.39M	35.78M	8.17M	8.17M	7.81M	8.17M	20.33M	26.65M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	47.05M	59.56M	90.11M	146.66M	7K	51K	14M	4.04M	16.82M	2.77M
Cash & Short-Term Investments	18.99M	23.05M	36.02M	80.89M	5K	24K	13.19M	3.59M	16.19M	2.38M
Cash Only	18.99M	23.05M	36.02M	80.89M	5K	24K	13.19M	3.59M	16.19M	2.38M
Short-Term Investments	0	0	0	0	0	0	0	0	0	0
Accounts Receivable	24.18M	26.86M	38.49M	52.63M	0	0	0	0	0	0
Days Sales Outstanding	49.43	47.05	48.98	48.09	-	-	-	-	-	-
Inventory	2.38M	5.18M	5.33M	7.32M	0	0	0	0	0	0
Days Inventory Outstanding	12.06	23.95	17.01	17.94	-	-	-	-	-	-
Other Current Assets	1.5M	4.48M	10.27M	5.82M	0	0	0	0	0	393K
Total Non-Current Assets+	77.1M	139.42M	434.45M	440.14M	0	0	806K	0	306K	506K
Property, Plant & Equipment	25.55M	25.82M	49.19M	48.38M	56.38M	0	0	0	256K	450K
Fixed Asset Turnover	6.99x	8.07x	5.83x	8.26x	-	-	-	-	-	-
Goodwill	29.83M	41.07M	223.1M	238.81M	301.32M	0	0	0	0	0
Intangible Assets	19.98M	33.47M	141.71M	129.65M	129.6M	0	0	0	0	0
Long-Term Investments	0	0	0	0	0	0	0	0	0	0
Other Non-Current Assets	1.73M	2.42M	2.77M	3.32M	-499.92M	0	806K	0	50K	56K
Total Assets+	124.14M	198.98M	524.56M	586.8M	7K	51K	14M	4.04M	17.13M	3.28M
Asset Turnover	1.44x	1.05x	0.55x	0.68x	-	-	-	-	-	-
Asset Growth %	-0.01%	0.6%	1.64%	0.12%	-1%	6.29%	273.47%	-0.71%	3.24%	-0.81%
Total Current Liabilities+	23.89M	31.51M	50.95M	49.62M	354K	4.84M	588K	1.67M	1.19M	1.62M
Accounts Payable	8.5M	12.43M	13.23M	18.16M	24.2M	474K	587K	1.66M	556K	531K
Days Payables Outstanding	43.1	57.49	42.2	44.48	-	-	-	-	-	-
Short-Term Debt	1.25M	1.25M	2.05M	5.13M	42K	4.29M	0	0	0	0
Deferred Revenue (Current)	1000K	1000K	1000K	1000K	-310	0	0	0	0	0
Other Current Liabilities	11.52M	13.86M	31.38M	23.26M	-23.89M	52K	0	0	636K	0
Current Ratio	1.97x	1.89x	1.77x	2.96x	0.02x	0.01x	23.81x	2.43x	14.09x	1.71x
Quick Ratio	1.87x	1.73x	1.66x	2.81x	0.02x	0.01x	23.81x	2.43x	14.09x	1.71x
Cash Conversion Cycle	18.4	13.51	23.8	21.54	-	-	-	-	-	-
Total Non-Current Liabilities+	24.33M	28.56M	223.9M	226.69M	3.38M	0	0	0	0	0
Long-Term Debt	21.94M	23.91M	197.31M	193.42M	3.38M	0	0	0	0	0
Capital Lease Obligations	0	0	0	0	0	0	0	0	0	0
Deferred Tax Liabilities	1.23M	0	0	0	0	0	0	0	0	0
Other Non-Current Liabilities	1.15M	4.65M	26.6M	33.27M	0	0	0	0	0	0
Total Liabilities	48.22M	60.07M	274.86M	276.32M	3.73M	4.84M	588K	1.67M	1.19M	1.62M
Total Debt+	23.19M	25.16M	199.36M	198.55M	3.42M	4.29M	0	0	0	0
Net Debt	4.21M	2.11M	163.33M	117.66M	3.42M	4.27M	-13.19M	-3.59M	-16.19M	-2.38M
Debt / Equity	0.31x	0.18x	0.80x	0.64x	-	-	-	-	-	-
Debt / EBITDA	0.64x	0.50x	3.02x	1.60x	-	-	-	-	-	-
Net Debt / EBITDA	0.12x	0.04x	2.48x	0.95x	-	-	-	-	-	-
Interest Coverage	-	-	7.63x	8.91x	-1.21x	-2.81x	-1.06x	-197.44x	-	-
Total Equity+	75.93M	138.91M	250.76M	310.49M	-3.73M	-4.79M	13.41M	2.37M	15.94M	1.65M
Equity Growth %	0.19%	0.83%	0.81%	0.24%	-1.01%	-0.28%	3.8%	-0.82%	5.71%	-0.9%
Book Value per Share	2.61	4.56	8.25	8.68	-0.46	-0.59	1.72	0.29	0.78	0.06
Total Shareholders' Equity	75.93M	138.91M	250.76M	310.49M	-3.73M	-4.79M	13.41M	2.37M	15.94M	1.65M
Common Stock	27K	28K	32K	33K	1K	0	1K	1K	3K	3K
Retained Earnings	-196.16M	-142.72M	-158.68M	-115.86M	-3.73M	-4.8M	-9.22M	-22.19M	-36.83M	-56.27M
Treasury Stock	0	0	0	0	0	0	0	0	0	0
Accumulated OCI	-54.58M	-60.07M	-71.9M	-67.2M	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	14.35M	38.85M	23.78M	72.75M	-218K	-600K	-3.23M	-9.95M	-12.09M	-14.47M
Operating CF Margin %	0.08%	0.19%	0.08%	0.18%	-	-	-	-	-	-
Operating CF Growth %	0.63%	1.71%	-0.39%	2.06%	-1%	-1.75%	-4.38%	-2.08%	-0.22%	-0.2%
Net Income	7.43M	53.44M	-15.96M	42.82M	-536K	-1.07M	-4.43M	-12.96M	-14.64M	-19.45M
Depreciation & Amortization	12.49M	14.27M	28.56M	40.17M	0	0	0	0	0	7K
Stock-Based Compensation	4.95M	6.5M	7.68M	0	0	10K	192K	1.12M	3.21M	4.3M
Deferred Taxes	245K	-38.14M	6.05M	-2.29M	0	0	0	0	0	0
Other Non-Cash Items	-19.77M	-2.11M	-13.65M	-75.09M	242K	276K	2.14M	0	0	0
Working Capital Changes	9.01M	4.9M	11.1M	57.88M	76K	182K	-1.14M	1.89M	-662K	671K
Change in Receivables	-7.68M	-25.55M	-19.1M	-40.92M	0	0	0	0	0	0
Change in Inventory	188K	-753K	665K	-1.99M	0	0	0	0	0	0
Change in Payables	-4.7M	3.15M	-9.62M	3.76M	0	0	0	1.53M	-471K	428K
Cash from Investing+	-13.6M	-36.18M	-177.19M	-28.85M	0	0	0	0	-256K	-201K
Capital Expenditures	-13.6M	-10.9M	-13.7M	-24.64M	0	0	0	0	-256K	-201K
CapEx % of Revenue	0.08%	0.05%	0.05%	0.06%	-	-	-	-	-	-
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	0	-25.28M	-162.17M	-4.21M	0	0	0	0	0	0
Cash from Financing+	-1.77M	1.43M	166.46M	601K	206K	619K	16.4M	350K	24.99M	866K
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	-1.77M	1.43M	166.46M	601K	0	0	0	2K	0	136K
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	750K	27.95M	10.09M	48.11M	-218K	-600K	-3.23M	-9.95M	-12.35M	-14.67M
FCF Margin %	0%	0.13%	0.04%	0.12%	-	-	-	-	-	-
FCF Growth %	1.19%	36.27%	-0.64%	3.77%	-1%	-1.75%	-4.38%	-2.08%	-0.24%	-0.19%
FCF per Share	0.03	0.92	0.33	1.34	-0.03	-0.07	-0.41	-1.22	-0.61	-0.55
FCF Conversion (FCF/Net Income)	1.93x	0.73x	-1.49x	1.70x	0.41x	0.56x	0.73x	0.77x	0.83x	0.74x
Interest Paid	0	0	0	0	0	0	0	0	0	0
Taxes Paid	0	0	0	0	0	0	0	0	0	0

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	10.64%	49.75%	-8.19%	15.26%	-0.35%	-	-102.68%	-164.24%	-159.89%	-221.11%
Return on Invested Capital (ROIC)	23.93%	24.32%	10.09%	14.96%	-0.1%	-	-	-	-	-
Gross Margin	59.69%	62.14%	60.11%	62.7%	-	-	-	-	-	-
Net Margin	4.16%	25.65%	-5.56%	10.72%	-	-	-	-	-	-
Debt / Equity	0.31x	0.18x	0.80x	0.64x	-	-	-	-	-	-
Interest Coverage	-	-	7.63x	8.91x	-1.21x	-2.81x	-1.06x	-197.44x	-	-
FCF Conversion	1.93x	0.73x	-1.49x	1.70x	0.41x	0.56x	0.73x	0.77x	0.83x	0.74x
Revenue Growth	7.16%	16.7%	37.65%	39.3%	-100%	-	-	-	-	-

Revenue by Segment

	2013	2014	2015	2016	2017	2018	2019
MonitoringCommercial	-	-	-	-	-	201.21M	218.27M
MonitoringCommercial Growth	-	-	-	-	-	-	8.48%
MonitoringMedicare	-	-	-	-	-	137.6M	153.74M
MonitoringMedicare Growth	-	-	-	-	-	-	11.73%
ClinicalTrialSupportandRelatedServices	-	-	-	-	-	50.56M	54.45M
ClinicalTrialSupportandRelatedServices Growth	-	-	-	-	-	-	7.69%
TechnologyDevicesConsumablesandRelatedServices	-	-	-	-	-	-	12.64M
TechnologyDevicesConsumablesandRelatedServices Growth	-	-	-	-	-	-	-
Patient Service	100.39M	133.18M	145.96M	165.66M	234.38M	-	-
Patient Service Growth	-	32.67%	9.60%	13.50%	41.48%	-	-
Research Services	20.33M	19.74M	21.85M	32.56M	38.79M	-	-
Research Services Growth	-	-2.88%	10.68%	49.02%	19.12%	-	-
Product	-	13.66M	10.7M	10.1M	13.6M	-	-
Product Growth	-	-	-21.67%	-5.55%	34.62%	-	-

Frequently Asked Questions

Growth & Financials

HeartBeam, Inc. (BEAT) grew revenue by 0.0% over the past year. Growth has been modest.

HeartBeam, Inc. (BEAT) reported a net loss of $20.6M for fiscal year 2024.

Dividend & Returns

HeartBeam, Inc. (BEAT) has a return on equity (ROE) of -221.1%. Negative ROE indicates the company is unprofitable.

HeartBeam, Inc. (BEAT) had negative free cash flow of $15.4M in fiscal year 2024, likely due to heavy capital investments.

US Stock Screener

...

HeartBeam, Inc. (BEAT) 10-Year Financial Performance & Capital Metrics

BEAT • • Industrial / General

HealthcareHealthcare ITTelehealth & Virtual Care PlatformsSpecialized Telehealth Solutions

Revenue $0
EBITDA -$20M
Net Income -$19M -32.9%
EPS (Diluted) -0.73 -1.4%
Gross Margin -
EBITDA Margin -
Operating Margin -
Net Margin -
ROE -221.11% -38.3%
ROIC -
Debt/Equity -
Interest Coverage -

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Momentum leader: RS Rating 91 (top 9%)

✗Weaknesses

✗Weak Piotroski F-Score: 1/9
✗Shares diluted 31.0% in last year
✗Trading more than 30% below 52-week high
✗Expensive at 35.4x book value
✗Low asset turnover indicates capital-intensive operations

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y-

3Y-

TTM-

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM-11.94%

EPS CAGR

10Y-

5Y-

3Y-

TTM5.71%

ROCE

10Y Avg-59.07%

5Y Avg-152.87%

3Y Avg-186.16%

Latest-226.1%

Peer Comparison

Specialized Telehealth Solutions

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
VSEEWVSee Health, Inc.	1.52M	0.09	-0.02	78.42%	-85.76%
VSEEVSee Health, Inc.	14.7M	0.44	-0.08	80.74%	-85.76%
MGRXMangoceuticals, Inc.	10.82M	0.66	-0.15	-15.81%	-42.45%	-126.03%		0.02
BEATHeartBeam, Inc.	75.78M	2.20	-3.01			-50.79%
OMDAOmada Health	906.26M	15.65	-18.41	38.29%	-16.82%	-16.98%		0.47
HNGEHinge Health, Inc.	1.66B	43.76	-291.73	33.37%	-3.06%	-2.83%	2.73%	0.03

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	178.51M	208.33M	286.78M	399.47M	0	0	0	0	0	0
Revenue Growth %	0.07%	0.17%	0.38%	0.39%	-1%	-	-	-	-	-
Cost of Goods Sold+	71.96M	78.88M	114.41M	148.99M	0	0	0	0	0	0
COGS % of Revenue	0.4%	0.38%	0.4%	0.37%	-	-	-	-	-	-
Gross Profit+	106.56M	129.45M	172.37M	250.49M	0	0	0	0	0	0
Gross Margin %	0.6%	0.62%	0.6%	0.63%	-	-	-	-	-	-
Gross Profit Growth %	0.14%	0.21%	0.33%	0.45%	-1%	-	-	-	-	-
Operating Expenses+	82.98M	93.59M	135.02M	166.48M	294K	788K	2.29M	13.03M	15.31M	19.89M
OpEx % of Revenue	0.46%	0.45%	0.47%	0.42%	-	-	-	-	-	-
Selling, General & Admin	75.87M	85.23M	123.92M	155.28M	253K	655K	2.03M	7.35M	8.52M	8.84M
SG&A % of Revenue	0.42%	0.41%	0.43%	0.39%	-	-	-	-	-	-
Research & Development	7.11M	8.36M	11.1M	11.21M	41K	133K	255K	5.68M	6.8M	11.05M
R&D % of Revenue	0.04%	0.04%	0.04%	0.03%	-	-	-	-	-	-
Other Operating Expenses	0	0	0	0	0	0	0	0	0	0
Operating Income+	23.58M	35.86M	37.35M	84M	-294K	-788K	-2.29M	-13.03M	-15.31M	-19.89M
Operating Margin %	0.13%	0.17%	0.13%	0.21%	-	-	-	-	-	-
Operating Income Growth %	1.06%	0.52%	0.04%	1.25%	-1%	-1.68%	-1.9%	-4.7%	-0.18%	-0.3%
EBITDA+	36.07M	50.13M	65.91M	124.17M	0	0	-2.29M	0	0	-19.88M
EBITDA Margin %	0.2%	0.24%	0.23%	0.31%	-	-	-	-	-	-
EBITDA Growth %	0.5%	0.39%	0.31%	0.88%	-1%	-	-	1%	-	-
D&A (Non-Cash Add-back)	12.49M	14.27M	28.56M	40.17M	294K	788K	0	13.03M	15.31M	7K
EBIT	0	0	-5.5M	50.93M	-294K	-788K	-2.29M	-12.96M	-14.64M	-19.89M
Net Interest Income+	0	0	0	0	-242K	-280K	-2.16M	0	675K	446K
Interest Income	0	0	0	0	0	0	2.17K	66K	675K	446K
Interest Expense	0	0	4.9M	9.43M	242K	280K	2.17M	66K	0	0
Other Income/Expense	-15.68M	-20.09M	-47.75M	-42.5M	-242K	-280K	-2.14M	69K	675K	439K
Pretax Income+	7.9M	15.77M	-10.4M	41.5M	-536K	-1.07M	-4.43M	-12.96M	-14.64M	-19.45M
Pretax Margin %	0.04%	0.08%	-0.04%	0.1%	-	-	-	-	-	-
Income Tax+	468K	-37.67M	6.75M	-370K	0	0	0	0	0	0
Effective Tax Rate %	0.94%	3.39%	1.53%	1.03%	1%	1%	1%	1%	1%	1%
Net Income+	7.43M	53.44M	-15.96M	42.82M	-536K	-1.07M	-4.43M	-12.96M	-14.64M	-19.45M
Net Margin %	0.04%	0.26%	-0.06%	0.11%	-	-	-	-	-	-
Net Income Growth %	1.76%	6.19%	-1.3%	3.68%	-1.01%	-0.99%	-3.15%	-1.93%	-0.13%	-0.33%
Net Income (Continuing)	7.43M	53.44M	-15.96M	42.82M	-536K	-1.07M	-4.43M	-12.96M	-14.64M	-19.45M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)+	0.26	1.75	-0.53	1.20	-0.10	-0.14	-0.56	-1.59	-0.72	-0.73
EPS Growth %	1.7%	5.73%	-1.3%	3.26%	-1.08%	-0.47%	-3%	-1.84%	0.55%	-0.01%
EPS (Basic)	0.27	1.91	-0.53	1.20	-0.10	-0.14	-0.56	-1.59	-0.72	-0.73
Diluted Shares Outstanding	29.09M	30.49M	30.39M	35.78M	8.17M	8.17M	7.81M	8.17M	20.33M	26.65M
Basic Shares Outstanding	27.12M	27.92M	30.39M	35.78M	8.17M	8.17M	7.81M	8.17M	20.33M	26.65M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	47.05M	59.56M	90.11M	146.66M	7K	51K	14M	4.04M	16.82M	2.77M
Cash & Short-Term Investments	18.99M	23.05M	36.02M	80.89M	5K	24K	13.19M	3.59M	16.19M	2.38M
Cash Only	18.99M	23.05M	36.02M	80.89M	5K	24K	13.19M	3.59M	16.19M	2.38M
Short-Term Investments	0	0	0	0	0	0	0	0	0	0
Accounts Receivable	24.18M	26.86M	38.49M	52.63M	0	0	0	0	0	0
Days Sales Outstanding	49.43	47.05	48.98	48.09	-	-	-	-	-	-
Inventory	2.38M	5.18M	5.33M	7.32M	0	0	0	0	0	0
Days Inventory Outstanding	12.06	23.95	17.01	17.94	-	-	-	-	-	-
Other Current Assets	1.5M	4.48M	10.27M	5.82M	0	0	0	0	0	393K
Total Non-Current Assets+	77.1M	139.42M	434.45M	440.14M	0	0	806K	0	306K	506K
Property, Plant & Equipment	25.55M	25.82M	49.19M	48.38M	56.38M	0	0	0	256K	450K
Fixed Asset Turnover	6.99x	8.07x	5.83x	8.26x	-	-	-	-	-	-
Goodwill	29.83M	41.07M	223.1M	238.81M	301.32M	0	0	0	0	0
Intangible Assets	19.98M	33.47M	141.71M	129.65M	129.6M	0	0	0	0	0
Long-Term Investments	0	0	0	0	0	0	0	0	0	0
Other Non-Current Assets	1.73M	2.42M	2.77M	3.32M	-499.92M	0	806K	0	50K	56K
Total Assets+	124.14M	198.98M	524.56M	586.8M	7K	51K	14M	4.04M	17.13M	3.28M
Asset Turnover	1.44x	1.05x	0.55x	0.68x	-	-	-	-	-	-
Asset Growth %	-0.01%	0.6%	1.64%	0.12%	-1%	6.29%	273.47%	-0.71%	3.24%	-0.81%
Total Current Liabilities+	23.89M	31.51M	50.95M	49.62M	354K	4.84M	588K	1.67M	1.19M	1.62M
Accounts Payable	8.5M	12.43M	13.23M	18.16M	24.2M	474K	587K	1.66M	556K	531K
Days Payables Outstanding	43.1	57.49	42.2	44.48	-	-	-	-	-	-
Short-Term Debt	1.25M	1.25M	2.05M	5.13M	42K	4.29M	0	0	0	0
Deferred Revenue (Current)	1000K	1000K	1000K	1000K	-310	0	0	0	0	0
Other Current Liabilities	11.52M	13.86M	31.38M	23.26M	-23.89M	52K	0	0	636K	0
Current Ratio	1.97x	1.89x	1.77x	2.96x	0.02x	0.01x	23.81x	2.43x	14.09x	1.71x
Quick Ratio	1.87x	1.73x	1.66x	2.81x	0.02x	0.01x	23.81x	2.43x	14.09x	1.71x
Cash Conversion Cycle	18.4	13.51	23.8	21.54	-	-	-	-	-	-
Total Non-Current Liabilities+	24.33M	28.56M	223.9M	226.69M	3.38M	0	0	0	0	0
Long-Term Debt	21.94M	23.91M	197.31M	193.42M	3.38M	0	0	0	0	0
Capital Lease Obligations	0	0	0	0	0	0	0	0	0	0
Deferred Tax Liabilities	1.23M	0	0	0	0	0	0	0	0	0
Other Non-Current Liabilities	1.15M	4.65M	26.6M	33.27M	0	0	0	0	0	0
Total Liabilities	48.22M	60.07M	274.86M	276.32M	3.73M	4.84M	588K	1.67M	1.19M	1.62M
Total Debt+	23.19M	25.16M	199.36M	198.55M	3.42M	4.29M	0	0	0	0
Net Debt	4.21M	2.11M	163.33M	117.66M	3.42M	4.27M	-13.19M	-3.59M	-16.19M	-2.38M
Debt / Equity	0.31x	0.18x	0.80x	0.64x	-	-	-	-	-	-
Debt / EBITDA	0.64x	0.50x	3.02x	1.60x	-	-	-	-	-	-
Net Debt / EBITDA	0.12x	0.04x	2.48x	0.95x	-	-	-	-	-	-
Interest Coverage	-	-	7.63x	8.91x	-1.21x	-2.81x	-1.06x	-197.44x	-	-
Total Equity+	75.93M	138.91M	250.76M	310.49M	-3.73M	-4.79M	13.41M	2.37M	15.94M	1.65M
Equity Growth %	0.19%	0.83%	0.81%	0.24%	-1.01%	-0.28%	3.8%	-0.82%	5.71%	-0.9%
Book Value per Share	2.61	4.56	8.25	8.68	-0.46	-0.59	1.72	0.29	0.78	0.06
Total Shareholders' Equity	75.93M	138.91M	250.76M	310.49M	-3.73M	-4.79M	13.41M	2.37M	15.94M	1.65M
Common Stock	27K	28K	32K	33K	1K	0	1K	1K	3K	3K
Retained Earnings	-196.16M	-142.72M	-158.68M	-115.86M	-3.73M	-4.8M	-9.22M	-22.19M	-36.83M	-56.27M
Treasury Stock	0	0	0	0	0	0	0	0	0	0
Accumulated OCI	-54.58M	-60.07M	-71.9M	-67.2M	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	14.35M	38.85M	23.78M	72.75M	-218K	-600K	-3.23M	-9.95M	-12.09M	-14.47M
Operating CF Margin %	0.08%	0.19%	0.08%	0.18%	-	-	-	-	-	-
Operating CF Growth %	0.63%	1.71%	-0.39%	2.06%	-1%	-1.75%	-4.38%	-2.08%	-0.22%	-0.2%
Net Income	7.43M	53.44M	-15.96M	42.82M	-536K	-1.07M	-4.43M	-12.96M	-14.64M	-19.45M
Depreciation & Amortization	12.49M	14.27M	28.56M	40.17M	0	0	0	0	0	7K
Stock-Based Compensation	4.95M	6.5M	7.68M	0	0	10K	192K	1.12M	3.21M	4.3M
Deferred Taxes	245K	-38.14M	6.05M	-2.29M	0	0	0	0	0	0
Other Non-Cash Items	-19.77M	-2.11M	-13.65M	-75.09M	242K	276K	2.14M	0	0	0
Working Capital Changes	9.01M	4.9M	11.1M	57.88M	76K	182K	-1.14M	1.89M	-662K	671K
Change in Receivables	-7.68M	-25.55M	-19.1M	-40.92M	0	0	0	0	0	0
Change in Inventory	188K	-753K	665K	-1.99M	0	0	0	0	0	0
Change in Payables	-4.7M	3.15M	-9.62M	3.76M	0	0	0	1.53M	-471K	428K
Cash from Investing+	-13.6M	-36.18M	-177.19M	-28.85M	0	0	0	0	-256K	-201K
Capital Expenditures	-13.6M	-10.9M	-13.7M	-24.64M	0	0	0	0	-256K	-201K
CapEx % of Revenue	0.08%	0.05%	0.05%	0.06%	-	-	-	-	-	-
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	0	-25.28M	-162.17M	-4.21M	0	0	0	0	0	0
Cash from Financing+	-1.77M	1.43M	166.46M	601K	206K	619K	16.4M	350K	24.99M	866K
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	-1.77M	1.43M	166.46M	601K	0	0	0	2K	0	136K
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	750K	27.95M	10.09M	48.11M	-218K	-600K	-3.23M	-9.95M	-12.35M	-14.67M
FCF Margin %	0%	0.13%	0.04%	0.12%	-	-	-	-	-	-
FCF Growth %	1.19%	36.27%	-0.64%	3.77%	-1%	-1.75%	-4.38%	-2.08%	-0.24%	-0.19%
FCF per Share	0.03	0.92	0.33	1.34	-0.03	-0.07	-0.41	-1.22	-0.61	-0.55
FCF Conversion (FCF/Net Income)	1.93x	0.73x	-1.49x	1.70x	0.41x	0.56x	0.73x	0.77x	0.83x	0.74x
Interest Paid	0	0	0	0	0	0	0	0	0	0
Taxes Paid	0	0	0	0	0	0	0	0	0	0

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	10.64%	49.75%	-8.19%	15.26%	-0.35%	-	-102.68%	-164.24%	-159.89%	-221.11%
Return on Invested Capital (ROIC)	23.93%	24.32%	10.09%	14.96%	-0.1%	-	-	-	-	-
Gross Margin	59.69%	62.14%	60.11%	62.7%	-	-	-	-	-	-
Net Margin	4.16%	25.65%	-5.56%	10.72%	-	-	-	-	-	-
Debt / Equity	0.31x	0.18x	0.80x	0.64x	-	-	-	-	-	-
Interest Coverage	-	-	7.63x	8.91x	-1.21x	-2.81x	-1.06x	-197.44x	-	-
FCF Conversion	1.93x	0.73x	-1.49x	1.70x	0.41x	0.56x	0.73x	0.77x	0.83x	0.74x
Revenue Growth	7.16%	16.7%	37.65%	39.3%	-100%	-	-	-	-	-

Revenue by Segment

	2013	2014	2015	2016	2017	2018	2019
MonitoringCommercial	-	-	-	-	-	201.21M	218.27M
MonitoringCommercial Growth	-	-	-	-	-	-	8.48%
MonitoringMedicare	-	-	-	-	-	137.6M	153.74M
MonitoringMedicare Growth	-	-	-	-	-	-	11.73%
ClinicalTrialSupportandRelatedServices	-	-	-	-	-	50.56M	54.45M
ClinicalTrialSupportandRelatedServices Growth	-	-	-	-	-	-	7.69%
TechnologyDevicesConsumablesandRelatedServices	-	-	-	-	-	-	12.64M
TechnologyDevicesConsumablesandRelatedServices Growth	-	-	-	-	-	-	-
Patient Service	100.39M	133.18M	145.96M	165.66M	234.38M	-	-
Patient Service Growth	-	32.67%	9.60%	13.50%	41.48%	-	-
Research Services	20.33M	19.74M	21.85M	32.56M	38.79M	-	-
Research Services Growth	-	-2.88%	10.68%	49.02%	19.12%	-	-
Product	-	13.66M	10.7M	10.1M	13.6M	-	-
Product Growth	-	-	-21.67%	-5.55%	34.62%	-	-

Frequently Asked Questions

Growth & Financials

HeartBeam, Inc. (BEAT) grew revenue by 0.0% over the past year. Growth has been modest.

HeartBeam, Inc. (BEAT) reported a net loss of $20.6M for fiscal year 2024.

Dividend & Returns

HeartBeam, Inc. (BEAT) has a return on equity (ROE) of -221.1%. Negative ROE indicates the company is unprofitable.

HeartBeam, Inc. (BEAT) had negative free cash flow of $15.4M in fiscal year 2024, likely due to heavy capital investments.